MFDS — authorised 28 January 2016
- Marketing authorisation holder: MERCK SHARP DOHME
- Status: likely_approved
🇰🇷 Zepatier in South Korea
MFDS authorised Zepatier on 28 January 2016
Marketing authorisation
Zepatier in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in South Korea
Frequently asked questions
Is Zepatier approved in South Korea?
Yes. MFDS authorised it on 28 January 2016.
Who is the marketing authorisation holder for Zepatier in South Korea?
MERCK SHARP DOHME holds the South Korean marketing authorisation.